Beryl Drugs Share Price
25 Aug, 2026 4:00 PM (IST)
Beryl Drugs Performance
- Today's Low
- ₹22
- Today's High
- ₹24
- 52 Week Low
- ₹16
- 52 Week High
- ₹30
- Open Price₹22
- Previous Close₹23
- Volume831
- 50 DMA₹22.40
- 100 DMA₹22.20
- 200 DMA₹22.40
Beryl Drugs Chart
Investment Returns
- Over 1 Month + 5.73%
- Over 3 Month + 13.58%
- Over 6 Month + 4.17%
- Over 1 Year + 2.13%
Smart Investing Starts Here Start SIP with Beryl Drugs for Steady Growth!
Beryl Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 18.3
- PEG Ratio
- 0.1
- Market Cap Cr
- 11
- P/B Ratio
- 1.1
- Average True Range
- 1.8
- EPS
- 1.2
- Dividend Yield
- 0
- MACD Signal
- 0.2
- RSI
- 49.2
- MFI
- 48.25
Latest Stock News Updates
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi
- BSE India
- 5 days 19 hours ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi
- BSE India
- 6 days 17 hours ago
NEWSPAPER PUBLICATION OF UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2026
- BSE India
- 1 week 5 days ago
Beryl Drugs Financials
Beryl Drugs Technicals
EMA & SMA
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹22.70
- 50 Day
- ₹22.40
- 100 Day
- ₹22.20
- 200 Day
- ₹22.40
Resistance and Support
- R3 24.50
- R2 24.00
- R1 23.20
- S1 22.00
- S2 21.50
- S3 20.80
Beryl Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-11 | Quarterly Results | |
| 2026-06-16 | Others | Inter alia, to consider and approve change in registered office of the company within local limits of the same city. |
| 2026-05-28 | Audited Results | |
| 2026-04-01 | Notice of EGM & Others | Inter-alia, to consider 1. Appointment of Mr. Shailendra Pathak as the Whole Time Director. 2. Appointment of Abhay Bhandari & Associates. 3. Authorize Directors of the Com. 4.Other business matters. |
| 2026-02-09 | Quarterly Results |
About Beryl Drugs
Beryl Drugs is principally engaged in manufacturing of bulk drugs View More- NSE Symbol
- BERLDRG
- BSE Symbol
- 524606
- ISIN
- INE415H01017
Similar Stocks to Beryl Drugs
Popular Stocks
Beryl Drugs FAQs
Beryl Drugs share price is ₹22 As on 26 August, 2026 | 04:20
The Market Cap of Beryl Drugs is ₹11.4 Cr As on 26 August, 2026 | 04:20
The P/E ratio of Beryl Drugs is 18.3 As on 26 August, 2026 | 04:20
The PB ratio of Beryl Drugs is 1.1 As on 26 August, 2026 | 04:20
The 52 week High & Low of Beryl Drugs is ₹30/₹15.9 respectively As on 26 August, 2026 | 04:20
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.